Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27433721 | 0.93 | CA5A (0.39) | CA5ACA5B | |
| SCHEMBL23269 | 0.93 | CA5A (0.39) | CA5ACA5B | |
| Ammonia Solution, Strong SCHEMBL5760496 | 0.89 | CA5A (0.36) | CA5ACA5B | |
| Water SCHEMBL384922 | 0.89 | CA5A (0.36) | CA5ACA5B | |
| SCHEMBL17510158 | 0.89 | CA5A (0.36) | CA5ACA5B | |
| SCHEMBL2571875 | 0.89 | CA5A (0.36) | CA5ACA5B | |
| SCHEMBL14974666 | 0.89 | CA5A (0.36) | CA5ACA5B | |
| SCHEMBL16756653 | 0.89 | CA5A (0.36) | CA5ACA5B | |
| Water SCHEMBL1614964 | 0.89 | CA5A (0.36) | CA5ACA5B | |
| SCHEMBL29170918 | 0.89 | CA5A (0.36) | CA5ACA5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114144407-B | Process for producing cyclic disulfonate compound | 住友精化株式会社 | 2024-02-13 | — | — | CN | disclosed |
| US-11742523-B2 | Electrolyte solutions | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2023-08-29 | — | — | US | disclosed |
| CN-114144407-A | Process for producing cyclic disulfonate compound | 住友精化株式会社 | 2022-03-04 | — | — | CN | disclosed |
| US-20210242503-A1 | ELECTROLYTE SOLUTIONS | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2021-08-05 | — | — | US | disclosed |
| EP-2067770-B1 | PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER | WAKO PURE CHEM IND LTD (JP) | 2017-04-12 | — | — | EP | disclosed |
| US-9583789-B2 | Non-aqueous electrolyte secondary battery | NEC CORPORATION (JP) | 2017-02-28 | — | — | US | disclosed |
| EP-2615682-B1 | ENERGY STORAGE ELEMENT, METHOD OF PRODUCING ENERGY STORAGE ELEMENT, AND NON-AQUEOUS ELECTROLYTE | GS YUASA INT LTD (JP) | 2016-10-19 | — | — | EP | disclosed |
| US-20150155597-A1 | NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | NEC CORPORATION (JP) | 2015-06-04 | — | — | US | disclosed |
| US-8986881-B2 | Energy storage element, method of producing energy storage element, and non-aqueous electrolyte | GS YUASA INTERNATIONAL LTD. (JP) | 2015-03-24 | — | — | US | disclosed |
| US-20130183580-A1 | ENERGY STORAGE ELEMENT, METHOD OF PRODUCING ENERGY STORAGE ELEMENT, AND NON-AQUEOUS ELECTROLYTE | GS YUASA INTERNATIONAL LTD. (JP) | 2013-07-18 | — | — | US | disclosed |
| US-8269038-B2 | Process for production of sulfonic acid ester | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-09-18 | — | — | US | disclosed |
| US-8124793-B2 | Derivatives of ethylene methanedisulfonate as cancer chemotherapeutic agents | CRONYN MARSHALL W (US) | 2012-02-28 | — | — | US | disclosed |
| US-20100041916-A1 | PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2010-02-18 | — | — | US | disclosed |
| US-20090176805-A1 | DERIVATIVES OF ETHYLENE METHANEDISULFONATE AS CANCER CHEMOTHERAPEUTIC AGENTS | CRONYN MARSHALL W | 2009-07-09 | — | — | US | disclosed |
| EP-2067770-A1 | PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER | Wako Pure Chemical Industries, Ltd. (JP) | 2009-06-10 | — | — | EP | disclosed |
| US-4950768-A | ANTICARCINOGENIC AGENTS | CRONYN MARSHALL W (US) | 1990-08-21 | — | — | US | disclosed |
| EP-0168478-B1 | CANCER CHEMOTHERAPEUTIC CYCLIC AND ACYCLIC DISULFONIC ESTER COMPOUNDS, METHOD OF USE THEREFOR, AND INTERMEDIATES | CRONYN, Marshall W. (US) | 1989-04-05 | — | — | EP | disclosed |
| EP-0168478-A4 | CANCER CHEMOTHERAPEUTIC CYCLIC AND ACYCLIC DISULFONIC ESTER COMPOUNDS, METHOD OF USE THEREFOR, AND INTERMEDIATES. | CRONYN MARSHALL W | 1986-11-07 | — | — | EP | disclosed |
| EP-0168478-A1 | CANCER CHEMOTHERAPEUTIC CYCLIC AND ACYCLIC DISULFONIC ESTER COMPOUNDS, METHOD OF USE THEREFOR, AND INTERMEDIATES. | CRONYN MARSHALL W | 1986-01-22 | — | — | EP | disclosed |
| WO-1985003075-A1 | CANCER CHEMOTHERAPEUTIC CYCLIC AND ACYCLIC DISULFONIC ESTER COMPOUNDS, METHOD OF USE THEREFOR, AND INTERMEDIATES | CRONYN MARSHALL W | 1985-07-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041916-A1 | PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER | SULT1A1, SULT2A1, STS | CA5A 1103/4885CA5B 1460/4885 |
| US-20090176805-A1 | DERIVATIVES OF ETHYLENE METHANEDISULFONATE AS CANCER CHEMOTHERAPEUTIC AGENTS | MGMT, ETV6, EI24 | CA5A 975/4885CA5B 1131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.